Now showing items 1-2 of 2

    • A cellular device to target cancer cells 

      Ostaku, Julian (Bilkent University, 2021-10)
      Cancer is the second leading cause of death globally, affecting one out of three people during their lifetime. Due to its severity and high incidence, numerous treatment methods have been implemented, with the Chimeric ...
    • Novel anti-HER2 monoclonal antibodies: synergy and antagonism with tumor necrosis factor-α 

      Ceran, Ceyhan; Çokol, M.; Cingöz, S.; Taşan, İpek; Öztürk, Mehmet; Yağcı, Tamer (BioMed Central, 2012)
      Background: One-third of breast cancers display amplifications of the ERBB2 gene encoding the HER2 kinase receptor. Trastuzumab, a humanized antibody directed against an epitope on subdomain IV of the extracellular domain ...